NHS Grampian launches pilot to diagnose bloodborne viruses

NHS Grampian has launched a pilot scheme aimed at diagnosing bloodborne viruses (BBVs) earlier – which improves outcomes and treatment options for patients. Early detection of hepatitis B, hepatitis C and HIV can be lifesaving, as they are treatable. But if left untreated they can lead to serious illness and death.

Direct sampling for calprotectin testing with new CALEX patient packs

Alpha Laboratories has introduced the latest advancement in faecal calprotectin extraction workflows. The CALEX Faecal Calprotectin Collection Kit is an innovative solution that enables patients to prepare and return their samples, revolutionising the traditional stool testing process. Stabilised samples arrive in the laboratory ready for processing and analysis.

Advanced Instruments welcomes new Key Account Manager for clinical portfolio in the UK

Advanced Instruments, a provider of analytical instruments and services for clinical and biopharmaceutical laboratories is delighted to welcome Jo Felix to the team as Key Account Manager for the Clinical Portfolio in the United Kingdom.

Two new blood tests part of Government’s £10 million medtech investment

As part of a £10 million funding package for boosting access to medical technology, eight innovative technology companies will be supported by the UK Government to bring their devices to market. New blood tests for identifying stroke patients and Alzheimer’s disease are two of the innovations to be supported.

OGT expands NGS operations with new facility

OGT, a leading global provider of genomic research and diagnostic solutions, has announced the opening of state-of-the-art facilities within the Oxford Technology Park. Equipped with cutting-edge technology, the facilities will drive development of OGT’s trusted SureSeq next generation sequencing (NGS) product portfolio, as well as deliver expert-led training and enhanced opportunities for collaboration.

Roche and PathAI enter digital pathology partnership

Roche has entered into an agreement with PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology. Under the terms of this agreement, PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop AI-enabled digital pathology algorithms in the companion diagnostics space.

February issue available now - update your PiP app!

The February issue of Pathology in Practice (PiP) has just been published – please read on to ensure you have the correct and up-to-date version of our app for your Apple or Android device.

Proscia receives FDA 510(k) clearance for Concentriq AP-Dx

Digital and computational pathology solution firm Proscia has announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Concentriq AP-Dx. The digital pathology solution was cleared for the purpose of primary diagnosis.

Leeds blood transfusion service live with Clinisys WinPath

The blood transfusion service in Leeds Teaching Hospitals NHS Trust has started working with a new LIMS, as part of a larger project to deploy a single LIMS across the West Yorkshire Association of Acute Trusts.

Paige expands its AppLab with six new applications

Digital pathology firm Paige has announced a significant expansion of its AppLab marketplace, with the addition of six new digital pathology and AI providers. New applications from Imagene, Histofy, Aiosyn, Clinsight, DoMore Diagnostics, and Stratipath, will be added to the AppLab to provide support for pathology laboratories worldwide in building deeply integrated and customised AI-enabled workflows.

Veracyte completes acquisition of C2i Genomics

Cancer diagnostics company Veracyte has announced it has completed its acquisition of C2i Genomics, adding whole-genome minimal residual disease (MRD) capabilities to its novel diagnostics platform and expanding the company’s ability to serve patients across the cancer care continuum.

Alpha Laboratories introduces FastZAP refills

Alpha Laboratories has made a further step in its drive to reduce the environmental impact of laboratory consumables with the introduction of FastZAP filter tip refills, which the company says represent a significant step forward in sustainability, while maintaining the quality and performance expected from ZAP premier filter tips.

Beckman Coulter Diagnostics appoints Kevin O’Reilly as new President

Beckman Coulter Diagnostics has appointed Kevin O’Reilly as its new president, succeeding Julie Sawyer Montgomery, who is now vice president and group executive at Danaher Diagnostics.

Updated NICE guidance recommends more targeting of antibiotics to combat sepsis 

NICE has updated its guidance for suspected sepsis, recommending better targeting of antibiotics to ensure the right people receive treatment as soon as possible but the medicines are not overused, which can lead to antibiotic resistance.

BIVDA appoints Professor Mike Messenger as Head of Regulatory Strategy

The British In Vitro Diagnostics Association (BIVDA) has announced the appointment of Professor Mike Messenger as Head of Regulatory Strategy from 1 March 2024.

Source Genomics expands portfolio with Element Bioscience’s AVITI

Source Genomics, a part of the Source BioScience Group, has expanded its genomic laboratory with the addition of an Element Biosciences AVITI System to its fleet of sequencers.

NHS launches national BRCA gene testing programme to identify cancer risk early

Tens of thousands of people with Jewish ancestry who are more likely to carry a genetic fault that can increase the risk of developing some cancers will receive genetic testing through a new programme announced by the NHS in England.

Hologic’s Genius Digital Diagnostics System cleared by FDA for cytology

Hologic has announced that its new Genius Digital Diagnostics System with the Genius Cervical AI algorithm has received clearance from the U.S. Food and Drug Administration (FDA). The Genius system combines deep-learning-based artificial intelligence (AI) with advanced volumetric imaging technology to help identify pre-cancerous lesions and cervical cancer cells.

US FDA to reclassify high-risk IVDs

The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) is to reclassify the highest risk in vitro diagnostic (IVD) devices, saying it is aiming to increase competition and increase access.

Aston University launches SPARK The Midlands to support health tech innovation

Aston University has hosted an event to celebrate the launch of SPARK The Midlands, a network which aims to bridge the gap between medical research discoveries of novel therapeutics, medical devices and diagnostics, and real-world clinical use.

Latest Issues

The Power to Disrupt - Clinical Diagnostics Expo UK

15 Hatfields
16 September, 2024

Microbe Conference 2024

Crowne Plaza Hotel, Sheffield, UK
20-22 September, 2024

Cardiac Marker Dialogues: Cardiac Biomarkers in Real Time – Experiences and Opportunities

Hilton Glasgow, 1 William Street, Glasgow, Scotland, G3 8HT
26-27 September, 2024

UK NEQAS: Navigating Quality Standards in Point of Care Testing

The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024